# Pycnogenol® in Post-COVID-19 Condition

> **NCT05890534** · PHASE3 · COMPLETED · sponsor: **University of Zurich** · enrollment: 153 (actual)

## Conditions studied

- Post COVID-19 Condition
- Long COVID

## Interventions

- **DRUG:** Pycnogenol®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05890534
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-07
- **Primary completion:** 2024-11-05
- **Final completion:** 2025-01-31
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890534, "Pycnogenol® in Post-COVID-19 Condition". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05890534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*